305 related articles for article (PubMed ID: 26683321)
1. Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.
El Defrawy AO; Gheita TA; Raslan HM; El Ansary MM; El Awar AH
Z Rheumatol; 2016 Nov; 75(9):917-923. PubMed ID: 26683321
[TBL] [Abstract][Full Text] [Related]
2. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
[TBL] [Abstract][Full Text] [Related]
3. Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays.
Lorenzo P; Aspberg A; Saxne T; Önnerfjord P
Osteoarthritis Cartilage; 2017 Sep; 25(9):1436-1442. PubMed ID: 28473207
[TBL] [Abstract][Full Text] [Related]
4. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
Wisłowska M; Jabłońska B
Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
[TBL] [Abstract][Full Text] [Related]
5. Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
Sakthiswary R; Rajalingam S; Hussein H; Sridharan R; Asrul AW
Clin Rheumatol; 2017 Dec; 36(12):2683-2688. PubMed ID: 28889184
[TBL] [Abstract][Full Text] [Related]
6. Early diagnostic and prognostic values of anti-cyclic citrullinated peptide antibody and cartilage oligomeric matrix protein in rheumatoid arthritis.
Algergawy SA; Abd El-Sabour M; Osman AS; Emam SM; Elham N
Egypt J Immunol; 2013; 20(2):11-20. PubMed ID: 24617043
[TBL] [Abstract][Full Text] [Related]
7. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
[TBL] [Abstract][Full Text] [Related]
8. Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
Dodge GR; Hawkins D; Boesler E; Sakai L; Jimenez SA
Osteoarthritis Cartilage; 1998 Nov; 6(6):435-40. PubMed ID: 10343777
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
Skoumal M; Kolarz G; Klingler A
Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
[TBL] [Abstract][Full Text] [Related]
10. COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations.
Happonen KE; Saxne T; Jacobsson L; Sturfelt G; Rönnelid J; Mollnes TE; Heinegård D; Turesson C; Blom AM
J Rheumatol; 2013 Dec; 40(12):2001-5. PubMed ID: 24187101
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between osteopontin and cartilage oligomeric matrix protein levels in joint synovial fluid of patients with knee osteoarthritis and disease severity].
Li XY; Shen ZX; Yang D
Zhongguo Gu Shang; 2022 Jul; 35(7):655-60. PubMed ID: 35859377
[TBL] [Abstract][Full Text] [Related]
12. Role of Serum cartilage oligomeric matrix protein (COMP) in the diagnosis of rheumatoid arthritis (RA): A case-control study.
Liu F; Wang X; Zhang X; Ren C; Xin J
J Int Med Res; 2016 Aug; 44(4):940-9. PubMed ID: 27217240
[TBL] [Abstract][Full Text] [Related]
13. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
[TBL] [Abstract][Full Text] [Related]
14. Cartilage oligomeric matrix protein and matrix metalloproteinase-3 expression in the serum and joint fluid of a reversible osteoarthritis rabbit model.
Chu XQ; Wang JJ; Dou LD; Zhao G
Genet Mol Res; 2015 Nov; 14(4):14207-15. PubMed ID: 26600478
[TBL] [Abstract][Full Text] [Related]
15. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.
Happonen KE; Saxne T; Aspberg A; Mörgelin M; Heinegård D; Blom AM
Arthritis Rheum; 2010 Dec; 62(12):3574-83. PubMed ID: 20737467
[TBL] [Abstract][Full Text] [Related]
16. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
Wisłowska M; Jabłońska B
Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
[TBL] [Abstract][Full Text] [Related]
17. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
[TBL] [Abstract][Full Text] [Related]
18. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study.
Georgiev T; Ivanova M; Kopchev A; Velikova T; Miloshov A; Kurteva E; Yuzeir K; Penkov M; Kabakchieva P; Rashkov R; Stoilov R
Rheumatol Int; 2018 May; 38(5):821-830. PubMed ID: 29164307
[TBL] [Abstract][Full Text] [Related]
19. Cartilage oligomeric matrix protein in serum and synovial fluid of rheumatoid arthritis: potential use as a marker for joint cartilage damage.
Momohara S; Yamanaka H; Holledge MM; Mizumura T; Ikari K; Okada N; Kamatani N; Tomatsu T
Mod Rheumatol; 2004; 14(5):356-60. PubMed ID: 17143693
[TBL] [Abstract][Full Text] [Related]
20. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.
Kokebie R; Aggarwal R; Lidder S; Hakimiyan AA; Rueger DC; Block JA; Chubinskaya S
Arthritis Res Ther; 2011 Mar; 13(2):R50. PubMed ID: 21435227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
